OCT in Rare Chorioretinal Diseases
This study is looking at how blood flows in the retina and choroid (parts of the back of your eye) using a special imaging technology called Optical Coherence Tomography (OCT) and OCT angiography. The goal is to see if rare eye diseases like Retinal Artery Occlusions or Central Serous Chorioretinopathy change blood flow compared to healthy eyes. Researchers also want to find out if areas with changed blood flow match up with areas of damage seen on other tests. You might be able to join if you are between 7 and 100 years old, have a diagnosed retinal or choroidal disease, and can complete study tests within 30 days. The study will measure your total retinal and choroidal blood flow after one year.
- Study design
- This is an observational study, meaning researchers will observe participants without providing specific interventions. It plans to enroll 150 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your total retinal and choroidal blood flow will be measured at one year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
OCT in Rare Chorioretinal Diseases
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Thomas Hwang, MD · PRINCIPAL_INVESTIGATOR · Oregon Health & Science Univeristy
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Total Retinal and Choroidal Blood FlowOne year
Determination whether disease affecting the retina and/or choroid shows a change in blood flow that differs from healthy eyes. Total retinal/choroidal blood flow will be measured in uL/min.